In conclusion, the results of this study demonstrated that DDTC is capable of inhibiting the PI3K/AKT/mTOR signaling activity within OC cells in vitro and in xenograft models, suggesting that this drug may be capable of inducing tumor cell apoptosis in part through this pathway. Here, MTOR is linked to neoplasm.